EGFR and neoplasm: About 2/3 of human cancers, include skin, colon, lung, and pancreatic cancer.[26] Studies have shown that in tumor patients, the activation of the ERBB signal pathway and the upregulation of its related genes can promote the transformation of normal cells into tumor cells.